share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Director Seidman Christine E

Merck & Co | 4: Statement of changes in beneficial ownership of securities

默沙东 | 4:持股变动声明
SEC announcement ·  03/29 16:19
Moomoo AI 已提取核心信息
Christine E. Seidman of Merck & Co., Inc. (MRK) engaged in a transaction involving the company's common stock on March 28, 2024. The action was executed with direct ownership, and post-transaction, Seidman holds a total of 100 shares of Merck & Co. The nature of the transaction and the number of shares involved were not specified in the announcement. The transaction reflects changes in the holdings of company insiders, which can be of interest to investors monitoring insider activities.
Christine E. Seidman of Merck & Co., Inc. (MRK) engaged in a transaction involving the company's common stock on March 28, 2024. The action was executed with direct ownership, and post-transaction, Seidman holds a total of 100 shares of Merck & Co. The nature of the transaction and the number of shares involved were not specified in the announcement. The transaction reflects changes in the holdings of company insiders, which can be of interest to investors monitoring insider activities.
默沙东公司(MRK)的克里斯汀·塞德曼于2024年3月28日参与了一项涉及公司普通股的交易。该行动由直接所有权执行,交易后,塞德曼共持有默沙东公司的100股股份。公告中没有具体说明交易的性质和所涉及的股票数量。该交易反映了公司内部人士持股量的变化,监督内幕活动的投资者可能会对此感兴趣。
默沙东公司(MRK)的克里斯汀·塞德曼于2024年3月28日参与了一项涉及公司普通股的交易。该行动由直接所有权执行,交易后,塞德曼共持有默沙东公司的100股股份。公告中没有具体说明交易的性质和所涉及的股票数量。该交易反映了公司内部人士持股量的变化,监督内幕活动的投资者可能会对此感兴趣。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息